Correlation Between NeuPath Health and Q2 Metals

Can any of the company-specific risk be diversified away by investing in both NeuPath Health and Q2 Metals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeuPath Health and Q2 Metals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NeuPath Health and Q2 Metals Corp, you can compare the effects of market volatilities on NeuPath Health and Q2 Metals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeuPath Health with a short position of Q2 Metals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeuPath Health and Q2 Metals.

Diversification Opportunities for NeuPath Health and Q2 Metals

-0.32

Correlation Coefficient

NeuPath Health  Q2 Metals

Very good diversification

The 3 months correlation between NeuPath and QTWO is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding NeuPath Health and Q2 Metals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Q2 Metals Corp and NeuPath Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeuPath Health are associated (or correlated) with Q2 Metals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Q2 Metals Corp has no effect on the direction of NeuPath Health i.e., NeuPath Health and Q2 Metals go up and down completely randomly.

Pair Corralation between NeuPath Health and Q2 Metals

Assuming the 90 days trading horizon NeuPath Health is expected to generate 2.05 times less return on investment than Q2 Metals. But when comparing it to its historical volatility, NeuPath Health is 2.0 times less risky than Q2 Metals. It trades about 0.06 of its potential returns per unit of risk. Q2 Metals Corp is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  68.00  in Q2 Metals Corp on September 23, 2024 and sell it today you would earn a total of  10.00  from holding Q2 Metals Corp or generate 14.71% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

NeuPath Health  vs.  Q2 Metals Corp

NeuPath Health

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in NeuPath Health are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, NeuPath Health showed solid returns over the last few months and may actually be approaching a breakup point.

Q2 Metals Corp

Risk-Adjusted Performance

4 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Q2 Metals Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Q2 Metals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with NeuPath Health and Q2 Metals

The main advantage of trading using opposite NeuPath Health and Q2 Metals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeuPath Health position performs unexpectedly, Q2 Metals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Q2 Metals will offset losses from the drop in Q2 Metals' long position.

The idea behind NeuPath Health and Q2 Metals Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.